英语新闻听写 FDA批准新型抗抑郁药物（在线收听）

UPI reports Food and Drug Administration has approved a prescription-only nasal spray to treat depression

UPI报道称食品药品监督管理局（FDA）批准了鼻腔喷雾剂可用于治疗抑郁症

marking the first medical advancement in fighting the affliction in more than 30 years.

标志着30多年来在抗击抑郁症上取得的首次医学进步。

The agency approved Johnson & Johnson's Spravato, which will carry the FDA's strongest box warning due to abuse potential.

管理局批准了美国强生的Spravato，由于其滥用潜力，Spravato将被贴有FDA最强的方框警告。

FDA Dr. Tiffany Farchione said in a statement

FDA的Tiffany Farchione博士在声明中表示

"There has been a long-standing need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition."

“长期以来我们都需要附加有效的方法来治疗耐药性抑郁症，这是一种严重且会危及生命的疾病。”